Article Details

Abbott, Roche and Danaher Lead $54 Billion U.S. In Vitro Diagnostic (IVD) Market

Retrieved on: 2022-11-16 00:14:43

Tags for this article:

Click the tags to see associated articles and topics

Abbott, Roche and Danaher Lead $54 Billion U.S. In Vitro Diagnostic (IVD) Market. View article details on hiswai:

Excerpt

Roche is second and Danaher (which includes Radiometer, Beckman Coulter and Cepheid) was third. These leading companies compete in a $54 billion ...

Article found on: www.prweb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up